Logo for CVRx Inc

CVRx Investor Relations Material

Latest events

Logo for CVRx Inc

Q4 2024

CVRx
Logo for CVRx

Q4 2024

4 Feb, 2025
Logo for CVRx

Q3 2024

29 Oct, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from CVRx Inc

Access all reports
CVRx develops and commercializes neuromodulation solutions for patients with heart failure. CVRx's first product, Barostim, is a investigational device that delivers low-energy electrical stimulation to the left ventricle through cardiac leads inserted into veins that leave the left ventricle.